Neuroprotective effect of Indian propolis in β-amyloid induced memory deficit: Impact on behavioral and biochemical parameters in rats

Biomedicine and Pharmacotherapy

Volumn 93, Issue , 2017, Pages 543-553

  Nanaware, Sadhana ^a   Shelar, Madhuri ^a   Sinnathambi, Arulmozhi ^a   Mahadik, K R ^a   Lohidasan, Sathiyanarayanan ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Acetylcholinesterase; Behavioural model; Brain derived neurotropic factor; Indian propolis; Neuroprotective activity; Oxidative stress

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN[25-35]; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN MONOAMINE; DONEPEZIL; MALONALDEHYDE; PROPOLIS; AMYLOID BETA PROTEIN; ANTIOXIDANT; CHOLINESTERASE INHIBITOR; NEUROPROTECTIVE AGENT; PLANT EXTRACT;

ADULT; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; BRAIN LEVEL; BRAIN TISSUE; CHOLINESTERASE INHIBITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; HISTOPATHOLOGY; MALE; MEMORY DISORDER; MORRIS WATER MAZE TEST; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIAL ARM MAZE TEST; RAT; TISSUE LEVEL; TREATMENT OUTCOME; ANIMAL; BRAIN; DRUG EFFECTS; MAZE TEST; MEMORY; METABOLISM; OXIDATIVE STRESS; WISTAR RAT;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANTS; BRAIN; CHOLINESTERASE INHIBITORS; COGNITIVE DYSFUNCTION; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PLANT EXTRACTS; PROPOLIS; RATS; RATS, WISTAR;

EID: 85021625381     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.06.072     Document Type: Article

References (64)

1. Kaur, R., Parveen, S., Mehan, S., Khanna, D., Kalra, S., Neuroprotective effect of ellagic acid against chronically scopolamine-induced Alzheimer's type memory and cognitive dysfunctions: possible behavioural and biochemical evidences. Int. J. Prev. Med. Res. 1 (2015), 45–64.
2. Blennow, K., De Leon, M.J., Zetterberg, H., Alzheimer's disease. Lancet 368 (2006), 387–403.
3. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L., Beyreuther, K., Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. 82 (1985), 4245–4249.
4. Kang, J., Lemaire, H.G., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K.H., Multhaup, G., Beyreuther, K., Muller-Hill, B., The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987), 19–25.
5. Aslam, M., Sial, A.A., Neuroprotective effect of ethanol extract of leaves of Malva parviflora against Amyloid-β-(A β−) mediated Alzheimer's disease. Int. Sch. Res. Not., 2014, 1–6.
6. Lu, P., Mamiya, T., Lu, L.L., Mouri, A., Zou, L.B., Nagai, T., Hiramatsu, M., Ikejim, T., Nabeshima, T., Silibinin prevents amyloid β peptide-induced memory impairment and oxidative stress in mice. Br. J. Pharmacol. 157 (2009), 1270–1277.
7. Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., et al. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. 92 (1995), 1989–1993.
8. Yankner, B.A., Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16 (1996), 921–932.
9. Trubetskaya, V.V., Stepanichev, M.Y., Onufriev, M.V., Lazareva, N.A., Markevich, V.A., Gulyaeva, N.V., Administration of aggregated beta-amyloid peptide 25–35 induces changes in long-term potentiation in the hippocampus in vivo. Neurosci. Behav. Physiol. 33 (2003), 95–98.
10. Tran, M.H., Yamada, K., Olariu, A., Mizuno, M., Ren, X.H., Nabeshima, T., Amyloid beta-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J. 15 (2001), 1407–1409.
11. Choi, J., Malakowsky, C.A., Talent, J.M., Conrad, C.C., Carroll, C.A., Weintraub, S.T., et al. Anti-apoptotic proteins are oxidized by A beta 25–35 in Alzheimer's fibroblasts. Biochim. Biophys. Acta 1637 (2003), 135–141.
12. Maurice, T., Lockhart, B.P., Privat, A., Amnesia induced in mice by centrally administered b-amyloid peptides involves cholinergic dysfunction. Brain Res. 706 (1996), 181–193.
13. Chen, J., Long, Y., Han, M., Wang, T., Chen, Q., Wang, R., Water-soluble derivative of propolis mitigates scopolamine-induced learning and memory impairment in mice. Pharmacol. Biochem. Behav. 90 (2008), 441–446.
14. Purohit, A., Joshi, K., Kotru, B., Kotru, S., Ram, H., Histological study of antiatherosclerotic effect of propolis in induced hypercholestrolemic male albino rabbits. Indian J. Fundam. Appl. Life Sci. 2 (2012), 384–390.
15. Purohit, A., Joshi, K., Kotru, B., Kotru, S., Effect of Indian propolis on haematological parameters in experimentally induced hyperlipidemic male albino rabbits. Asian J. Pharm. Clin. Res. 6 (2013), 17–19.
16. Kalia, P., Kumar, N.R., Harjai, K., Phytochemical screening and antibacterial activity of different extracts of Propolis. Int. J. Pharm. Biol. Res. 3 (2013), 219–222.
17. Naik, D.G., Mujumdar, A.M., Vaidya, H.S., Anti-inflammatory activity of propolis from Maharashtra, India. J. Apic. Res. 52 (2013), 35–43.
18. Ambardekar, R., Gilda, S., Mahadik, K., Harsulkar, A., Paradkar, A., Free radical scavenging and anti-inflammatory activity of Indian Propolis. Pharmacologyonline 3 (2009), 991–1002.
19. Naik, D.G., Vaidya, H.S., Antioxidant properties of volatile oil of Indian Propolis. J. Apiprod. Apimed. Sci. 3 (2011), 89–93.
20. Ramadan, A., Soliman, G., Mahmoud, S.S., Nofal, S.M., Abdel-Rahman, R.F., Evaluation of the safety and antioxidant activities of Crocus sativus and Propolis ethanolic extracts. J. Saudi Chem. Soc. 16 (2012), 13–21.
21. Miguel, M.D.G., Doughmi, O., Aazza, S., Antunes, D., Lyoussi, B., Antioxidant, anti-inflammatory and acetylcholinesterase inhibitory activities of propolis from different regions of Morocco. Food Sci. Biotechnol. 23 (2014), 312–322.
22. El-Hady, F.K.A., Souleman, A.M.A., El-Shahid, Z.A., Antiacetylcholinesterase and cytotoxic activities of Egyptian propolis with correlation to its GC/MS and HPLC analysis. Int. J. Pharm. Sci. 34 (2015), 32–42.
23. Shimazawa, M., Chikamatsu, S., Morimoto, N., Mishima, S., Nagai, H., Hara, H., Neuroprotection by Brazilian green propolis against In vitro and In vivo ischemic neuronal damage. eCAM 2 (2005), 201–207.
24. Ilhan, A., Iraz, M., Gurel, A., Amrutcu, F., Akyol, O., Caffeic acid phenethyl ester exerts a neuroprotective effect on CNS against pentylenetetrazol-induced seizures in mice. Neurochem. Res. 29 (2004), 2287–2292.
25. Liu, R., Wu, C.X., Zhou, D., Yang, F., Tian, S., Zhang, L., Zhang, T.T., Du, G.H., Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis. BMC Med. 10 (2012), 1–21.
26. Lei, Y., Chen, J., Zhang, W., Fu, W., Wu, G., Wei, H., Wang, Q., Raun Raun, J., In vivo investigation of the potential of galangin, kaempferol and myricetin for the protection of D-galactose-induced cognitive impairment. Food Chem. 135 (2012), 2702–2707.
27. Trusheva, B., Trunkova, D., Bankova, V., Different extraction methods of biologically active components from propolis: a preliminary study. Chem. Cent. J. 7 (2007), 1–13.
28. Marinova, D., Ribarova, F., Atanassova, M., Total phenolics and total flavonoids in Bulgarian fruits and vegetables. J. Univ. Chem. Technol. Metall. 40 (2005), 255–260.
29. Paxinos, G., Watson, C., The Rat Brain in Stereotaxic Coordinates. 6th edition, 2006, Academic Press.
30. OECD/OCDE 425, Acute Oral Toxicity. Guideline for the Testing of Chemicals, Revised Draft Guideline, vol. 425, (2001) 5–6.
31. Vorhees, C.V., Williams, M.T., Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1 (2006), 848–858.
32. Hritcu, L., Cioanca, O., Hancianu, M., Effects of lavender oil inhalation on improving scopolamine-induced spatial memory impairment in laboratory rats. Phytomedicine 19 (2012), 529–534.
33. Olton, D.S., Samuelson, R.J., Remembrance of places passed: spatial memory in rats. J. Exp. Psychol. Anim. B 2 (1976), 97–116.
34. Wilcock, D.M., Gordon, M.N., Morgan, D., Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain. Nat. Protoc. 1 (2006), 1591–1595.
35. Misra, H.P., Fridovich, I., The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247 (1972), 3170–3175.
36. Moron, M.S., Depierre, J.W., Mannervik, B., Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta 582 (1979), 67–78.
37. Rao, S., Nitric oxide scavenging by curcuminoids. J. Pharm. Pharmacol. 49 (1997), 105–107.
38. Beers, R.F. Jr., Sizer, I.W., A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195 (1952), 133–140.
39. Gratto, D., Santa maria, L.D., Boeira, S., Valentini, J., Charao, M.F., Moro, A.M., Nascimento, P.C., Pomblum, V.J., Garcia, S.C., Rapid quantification of malondialdehyde in plasma by high-performance liquid chromatography- visible detection. J. Pharm. Biomed. Anal. 43 (2007), 619–624.
40. Lakshmana, M.K., Raju, T.R., An isocratic assay for norepinephrine, dopamine, and 5-hydroxytryptamine using their native fluorescence by high-performance liquid chromatography with fluorescence detection in discrete brain areas of rat. Anal. Biochem. 246 (1997), 166–170.
41. Kumar, A., Prakash, A., Dogra, S., Centella asiatica attenuates d-galactose-induced cognitive impairment, oxidative and mitochondrial dysfunction in mice. Int. J. Alzheimers Dis., 2011, 1–9.
42. Kim, H.J., Lee, K.W., Lee, H.J., Protective effects of piceatannol against beta-amyloid-induced neuronal cell death. Ann. N. Y. Acad. Sci. 1095 (2007), 473–482.
43. Nie, B.M., Jiang, X.Y., Cai, J.X., Fu, S.L., Yang, L.M., Lin, L., et al. Panaxydol and panaxynol protect cultured cortical neurons against Abeta25–35-induced toxicity. Neuropharmacology 54 (2008), 845–853.
44. Pike, C.J., Walencewicz-Wasserman, A.J., Kosmoski, J., Cribbs, D.H., Glabe, C.G., Cotman, C.W., Structure-activity analyses of b-Amyloid peptides: contributions of the b25-35 region to aggregation and neurotoxicity. J. Neurochem. 64 (1995), 253–265.
45. Kubo, T., Nishimura, S., Kumagae, Y., Kaneko, I., In vivo conversion of racemized beta-amyloid ([D-Ser 26]Abeta 1–40) to truncated and toxic fragments ([D-Ser 26]Abeta 25–35/40) and fragment presence in the brains of Alzheimer's patients. J. Neurosci. Res. 70 (2002), 474–483.
46. Alkam, T., Nitta, A., Mizoguchi, H., Saito, K., Seshima, M., Itoh, A., et al. Restraining tumor necrosis factor-alpha by thalidomide prevents the Amyloid b-induced impairment of recognition memory in mice. Behav. Brain Res. 189 (2008), 100–106.
47. Pu, F., Mishima, K., Irie, K., Motohashi, K., Tanaka, Y., Orito, K., Egawa, T., Kitamura, Y., Egashira, N., Iwasaki, K., Fujiwara, M., Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J. Pharmacol. Sci. 104 (2007), 329–334.
48. Smith, M.A., Perry, G., Richey, P.L., Sayre, L.M., Anderson, V.E., Beal, M.F., et al. Oxidative damage in Alzheimer's. Nature 382 (1996), 120–121.
49. Aksenov, M.Y., Markesbery, W.R., Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci. Lett. 302 (2001), 141–145.
50. Mann, H., McCoy, M.T., Subramaniam, J., Van Remmen, H., Cadet, J.L., Overexpression of superoxide dismutase and catalase in immortalized neural cells: toxic effects of hydrogenperoxide. Brain Res. 770 (1997), 163–168.
51. Slater, T.F., Overview of the methods used for detecting lipid peroxidation. Methods Enzymol. 105 (1984), 283–293.
52. Markesbery, W.R., Lovell, M.A., Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19 (1998), 33–36.
53. Skoumalova, A., Hort, J., Blood markers of oxidative stress in Alzheimer's disease. J. Cell. Mol. Med. 16 (2012), 2291–2300.
54. Lee, S.C., Linh, P.T., Jing, Z., Ryu, S.Y., Myung, C.S., Kim, Y.H., Kang, J.S., Effects of repeated administration of Uncaria hooks on the acquisition and central neuronal activities in ethanol-treated mice. J. Ethanopharmacol. 94 (2004), 123–128.
55. Ganong, W.F., Neural basis of instinctual behaviour and emotions. Dolan, J., Langan, C., (eds.) Review of Medical Physiology, 1991, Prentice-Hall International Inc., USA, 239–242.
56. Eagle, D.M., Humby, T., Dunnet, S.B., Robbins, T.W., Effect of regional striatal lesions on motor, motivational and executive aspects of progressive ratio performance in rats. Behav. Neurosci. 113 (1999), 718–731.
57. Trond, M., Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioural tasks. Brain Res. Rev. 41 (2003), 268–287.
58. Stahl, S.M., Neurotransmission of cognition, part3 Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in pre frontal cortex. J. Clin. Psychiatry 64 (2003), 230–231.
59. Ganguly, R., Guha, D., Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer's disease & protection by Moringa oleifera. Ind. J. Med. Res. 128 (2008), 744–751.
60. Milatovic, D., Gupta, R.C., Aschner, M., Anticholinesterase toxicity and oxidative stress. Sci. World J. 6 (2006), 295–310.
61. Lewis, P.R., Shute, C.C.D., Confirmation from choline acetylase analyses of massive cholinergic innervations to the hippocampus. J. Physiol. 172 (1964), 9–10.
62. Blokland, A., Acetylcholine: a neurotransmitter for learning and memory?. Brain Res. Rev. 21 (1995), 285–300.
63. Yang, J.L., Lin, Y.T., Chuang, P.C., Bohr, V.A., Mattson, M.P., BDNF and Exercise enhance neuronal DNA repair by stimulating CREB-mediated production of Apurinic/apyrimidinic endonuclease 1. Neuromol. Med. 16 (2014), 161–174.
64. Budni, J., Bellettini-Santos, T., Mina, F., Garcez, M.L., Zugno, A.I., The involvement of BDNF: NGF and GDNF in aging and Alzheimer's disease. Aging Dis. 6 (2016), 331–341.